https://medicaex.com/prnewswire/chinas-optimization-of-control-measures-lays-solid-foundation-for-covid-19-response/ 2023-01-04T08:12:11+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-new-strategic-plans-reinforcing-transformation-into-a-fully-integrated-biopharmaceutical-company/ 2023-01-04T07:12:14+00:00 https://medicaex.com/prnewswire/clarivate-and-the-chinese-academy-of-sciences-release-annual-joint-report-to-identify-165-research-fronts/ 2023-01-04T07:12:14+00:00 https://medicaex.com/prnewswire/pentax-medical-u-s-launches-endoscope-drying-solution-plasmatyphoondry/ 2023-01-04T02:12:16+00:00 https://medicaex.com/prnewswire/antengene-to-present-at-the-41st-annual-j-p-morgan-healthcare-conference/ 2023-01-04T02:12:11+00:00 https://medicaex.com/prnewswire/bridge-biotherapeutics-to-present-at-biotech-showcase-2023/ 2023-01-03T15:12:27+00:00 https://medicaex.com/prnewswire/exclusive-pepaminto-topper-wins-ces-2023-innovation-award/ 2023-01-03T15:12:27+00:00 https://medicaex.com/prnewswire/zircon-phase-iii-renal-cancer-study-to-be-presented-at-asco-gu-along-with-theranostic-pipeline-advances/ 2023-01-03T14:12:23+00:00 https://medicaex.com/prnewswire/sanisure-announces-the-acquisition-of-a-leading-silicone-extrusion-facility-in-twinsburg-ohio/ 2023-01-03T14:12:19+00:00 https://medicaex.com/prnewswire/steakholder-foods-receives-grant-of-up-to-1m-for-collaboration-with-umami-meats-to-3d-bio-print-structured-cultivated-fish-products/ 2023-01-03T13:12:07+00:00 https://medicaex.com/prnewswire/nuevocor-to-present-at-biotech-showcase-during-jpm-week-and-at-keystone-symposium-on-heart-development-and-disease/ 2023-01-03T12:12:25+00:00 https://medicaex.com/prnewswire/antengene-announces-hrec-approval-in-australia-for-the-phase-i-trial-of-atg-022-claudin-18-2-adc-in-patients-with-advanced-or-metastatic-solid-tumors/ 2023-01-03T12:12:17+00:00 https://medicaex.com/prnewswire/everest-medicines-to-hold-new-corporate-strategy-online-conference-calls/ 2023-01-03T12:12:15+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-china-nmpa-recommends-priority-review-for-nefecon-for-the-treatment-of-primary-iga-nephropathy/ 2023-01-03T08:12:12+00:00 https://medicaex.com/prnewswire/cstone-announces-the-registrational-clinical-trial-of-sugemalimab-as-first-line-treatment-in-patients-with-esophageal-squamous-cell-carcinoma-met-primary-endpoints-and-plans-to-submit-a-supplemental-n/ 2023-01-03T01:12:12+00:00 https://medicaex.com/prnewswire/china-pharma-holdings-inc-announced-the-launch-of-n95-medical-protective-mask/ 2023-01-03T00:12:13+00:00 https://medicaex.com/prnewswire/china-actively-optimizes-covid-19-response-measures-to-better-prepare-for-challenges/ 2023-01-03T00:12:10+00:00 https://medicaex.com/prnewswire/cgtn-new-approaches-how-china-stepped-up-its-covid-19-treatments/ 2023-01-02T23:12:09+00:00 https://medicaex.com/prnewswire/cgtn-new-approaches-how-china-pushes-covid-19-vaccine-rd-and-inoculation/ 2023-01-02T22:12:08+00:00 https://medicaex.com/prnewswire/ascletis-believes-that-the-complaints-made-by-viking-therapeutics-have-no-merit-and-will-vigorously-defend-against-such-complaints/ 2023-01-02T12:12:19+00:00 https://medicaex.com/prnewswire/everest-medicines-commences-operations-at-its-mrna-vaccine-manufacturing-facility-accelerating-evolution-to-a-fully-integrated-biopharma/ 2022-12-30T13:12:12+00:00 https://medicaex.com/prnewswire/phase-ii-iii-clinical-trial-of-simceres-3cl-targeting-anti-sars-cov-2-drug-candidate-complete-all-patients-enrollment/ 2022-12-30T13:12:09+00:00 https://medicaex.com/prnewswire/edan-medical-uk-pointed-out-the-trend-of-healthcare-innovation-on-the-interview-broadcasted-on-sky-tv/ 2022-12-30T12:12:14+00:00 https://medicaex.com/prnewswire/promising-singaporean-medtech-firm-osteopore-achieves-record-revenue-enters-new-markets-and-operates-in-all-major-continents-in-2022/ 2022-12-30T12:12:10+00:00 https://medicaex.com/prnewswire/brii-biosciences-provides-update-on-strategic-clinical-development-progress/ 2022-12-30T05:12:11+00:00 https://medicaex.com/prnewswire/complete-genomics-to-present-its-multiple-innovative-sequencing-platforms-at-biotech-showcase-2023/ 2022-12-29T19:12:06+00:00 https://medicaex.com/prnewswire/carrick-therapeutics-and-the-menarini-group-announce-clinical-trial-collaboration-to-evaluate-samuraciclib-and-elacestrant-combination/ 2022-12-29T15:12:18+00:00 https://medicaex.com/prnewswire/ablaze-pharmaceuticals-and-yonghe-pharma-initiate-development-and-manufacturing-services-agreement-for-targeted-radiopharmaceutical-therapies/ 2022-12-29T15:12:12+00:00 https://medicaex.com/prnewswire/cgtn-new-approaches-why-china-is-easing-its-covid-19-curbs-now/ 2022-12-29T14:12:09+00:00 https://medicaex.com/prnewswire/wetrade-group-pushes-further-into-the-new-energy-cooperated-with-super-solar-energy/ 2022-12-29T13:12:06+00:00 https://medicaex.com/prnewswire/duoning-maintains-supply-chain-stability-with-operation-of-factory-in-wuxi/ 2022-12-29T13:12:06+00:00 https://medicaex.com/prnewswire/neurophth-receives-ind-clearance-from-fda-for-aav-nd1-gene-therapy-of-lhon/ 2022-12-29T06:12:19+00:00 https://medicaex.com/prnewswire/genequantum-and-wuxi-xdc-entered-into-strategic-collaboration-to-empower-innovative-bioconjugate-development/ 2022-12-29T06:12:12+00:00 https://medicaex.com/prnewswire/bioved-pharmaceuticals-inc-announces-the-results-of-its-phase-iii-randomized-clinical-trial-in-moderate-covid-19-with-artovid-20-a-natural-plant-based-oral-product/ 2022-12-29T03:12:09+00:00 https://medicaex.com/prnewswire/health-and-hydrogen-launches-one-of-the-first-medical-grade-molecular-hydrogen-inhalation-machine-hah-301/ 2022-12-28T14:12:17+00:00 https://medicaex.com/prnewswire/cj-cheiljedang-and-emmyon-inc-sign-a-licensing-agreement-to-commercialize-a-dietary-supplement-with-natural-extracts-for-use-in-significant-improvement-of-skeletal-muscle-mass-and-function-in-human/ 2022-12-28T13:12:10+00:00 https://medicaex.com/prnewswire/novavax-announces-proposed-offering-of-125-million-of-convertible-senior-notes/ 2022-12-28T13:12:08+00:00 https://medicaex.com/prnewswire/wetrade-group-and-kunyue-medical-reached-cooperation-online-store-epidemic-inspection-pass-has-achieved-a-daily-average-of-50000-online-sales-orders/ 2022-12-28T13:12:05+00:00 https://medicaex.com/prnewswire/hyphens-pharma-licenses-winlevi-for-all-10-asean-countries-from-cosmo-pharmaceuticals/ 2022-12-28T00:12:11+00:00 https://medicaex.com/prnewswire/international-collaboration-to-improve-cancer-care-in-sub-saharan-africa-focuses-on-resources-for-childrens-cancers/ 2022-12-27T16:12:06+00:00 https://medicaex.com/prnewswire/the-top-3-best-places-to-work-in-indonesia-for-2022-revealed/ 2022-12-27T14:12:07+00:00 https://medicaex.com/prnewswire/waterdrop-listed-among-beijings-top-100-enterprises-in-digital-economy/ 2022-12-27T14:12:07+00:00 https://medicaex.com/prnewswire/pvmed-raises-us-14-million-series-a-funding-from-cherami-philips-jhf-cococapital-and-strategy-capital/ 2022-12-27T12:12:11+00:00 https://medicaex.com/prnewswire/juniper-biologics-wins-ma-award-2022-by-acquisition-international/ 2022-12-27T12:12:11+00:00 https://medicaex.com/prnewswire/cgtn-how-china-strengthens-vaccine-cooperation-to-battle-covid-19/ 2022-12-27T10:12:08+00:00 https://medicaex.com/prnewswire/china-and-asean-deepened-exchanges-and-cooperation-on-traditional-medicine/ 2022-12-27T07:12:15+00:00 https://medicaex.com/prnewswire/novavax-announces-proposed-125-million-public-offering-of-common-stock/ 2022-12-27T02:12:09+00:00 https://medicaex.com/prnewswire/mindrank-announces-u-s-fda-clearance-of-ind-application-for-mdr-001-a-novel-glp-1-receptor-agonist-for-the-treatment-of-type-2-diabetes-and-obesity/ 2022-12-26T16:12:11+00:00 https://medicaex.com/prnewswire/in-vitro-fertilization-services-industry-to-be-boosted-by-innovative-technologies/ 2022-12-26T09:12:05+00:00 https://medicaex.com/prnewswire/e-home-household-services-holdings-limiteds-subsidiary-zhong-run-launches-cloud-pharmacy-service-to-address-new-situation-of-epidemic-prevention-and-control/ 2022-12-26T05:12:12+00:00 https://medicaex.com/prnewswire/superior-neutralizing-antibody-titer-levels-against-omicron-bf-7-and-ba-2-75-of-the-companys-two-component-recombinant-covid-19-vaccine-recov-as-compared-to-international-mainstream-mrna-vaccine/ 2022-12-26T04:12:06+00:00 https://medicaex.com/prnewswire/magnetic-resonance-imaging-market-to-witness-growth-due-to-the-increasing-demand-for-scans/ 2022-12-24T12:12:18+00:00 https://medicaex.com/prnewswire/gemini-rosemont-adds-peninsula-life-science-center-eight-story-office-building-to-portfolio-in-all-cash-transaction/ 2022-12-24T12:12:14+00:00 https://medicaex.com/prnewswire/everest-medicines-licensing-partner-pfizer-announces-fda-and-ema-acceptance-of-etrasimod-regulatory-submissions-for-ulcerative-colitis/ 2022-12-23T09:12:14+00:00 https://medicaex.com/prnewswire/antengene-announces-nda-submission-for-xpovio-in-macau-malaysia-and-thailand-for-relapsed-refractory-multiple-myeloma-and-relapsed-refractory-diffuse-large-b-cell-lymphoma/ 2022-12-23T01:12:11+00:00 https://medicaex.com/prnewswire/possible-breakthrough-in-cardiovascular-disease-diagnostics-for-the-united-states/ 2022-12-22T14:12:17+00:00 https://medicaex.com/prnewswire/genfleet-therapeutics-and-merck-enter-into-trial-collaboration-to-initiate-study-investigating-combination-therapy-of-gfh925-kras-g12c-inhibitor-and-erbitux-cetuximab/ 2022-12-22T12:12:23+00:00 https://medicaex.com/prnewswire/qurebio-ltd-to-present-its-q-1802-clinical-phase-%e2%85%b0-data-at-2023-asco-gi-meetings/ 2022-12-22T12:12:12+00:00 https://medicaex.com/prnewswire/possible-breakthrough-in-cardiovascular-disease-diagnostics-for-southeast-asia/ 2022-12-22T08:17:58+00:00 https://medicaex.com/prnewswire/genscript-probio-congratulates-selecxines-ind-clearance-from-mfds/ 2022-12-22T08:13:44+00:00 https://medicaex.com/prnewswire/wuxi-apptec-named-to-the-2022-dow-jones-sustainability-world-index/ 2022-12-22T08:13:42+00:00 https://medicaex.com/prnewswire/sirnaomics-announces-interim-data-from-phase-i-clinical-trial-of-rnai-therapeutic-stp707-for-treatment-of-multiple-solid-tumors/ 2022-12-22T00:12:11+00:00 https://medicaex.com/prnewswire/zhejiang-doer-biologics-announces-clinical-trial-collaboration-with-msd-to-evaluate-dr30303-in-combination-with-keytruda-pembrolizumab-in-patients-with-gastric-or-gastroesophageal-junction-can/ 2022-12-21T22:12:18+00:00 https://medicaex.com/prnewswire/waterdrop-chief-actuary-hui-teng-good-products-and-services-are-the-underlying-logic-of-high-quality-transformation-for-health-insurance/ 2022-12-21T14:17:47+00:00 https://medicaex.com/prnewswire/astrazenca-g42-healthcare-enter-strategic-partnership-to-manufacture-pharmaceutical-products-in-abu-dhabi/ 2022-12-21T13:12:14+00:00 https://medicaex.com/prnewswire/cgtn-new-approaches-hospitals-gear-up-to-prioritize-covid-19-patients/ 2022-12-21T10:12:09+00:00 https://medicaex.com/prnewswire/ces-2023-omron-healthcare-introducing-initiatives-to-advance-its-vision-of-going-for-zero-elimination-of-heart-attack-and-stroke/ 2022-12-21T07:12:19+00:00 https://medicaex.com/prnewswire/medidata-awarded-international-innovation-award-for-medidata-sensor-cloud/ 2022-12-21T07:12:13+00:00 https://medicaex.com/prnewswire/kira-pharmaceuticals-announces-clearance-to-initiate-phase-2-evaluation-of-kp104-in-iga-nephropathy-igan-and-complement-3-glomerulopathy-c3g-in-china-and-australia/ 2022-12-21T06:12:14+00:00 https://medicaex.com/prnewswire/pepromene-bio-inc-announced-complete-response-of-the-first-patient-treated-in-its-b-cell-non-hodgkin-lymphoma-b-nhl-phase-1-clinical-trial-of-pmb-ct01-baffr-car-t-cells-at-city-of-hope/ 2022-12-21T02:12:13+00:00 https://medicaex.com/prnewswire/ascletis-nash-drug-asc41thr%ce%b2-phase-ii-enrollment-is-progressing-as-planned/ 2022-12-21T01:12:13+00:00 https://medicaex.com/prnewswire/mabwell-bioscience-partners-with-binnopharm-group-to-market-9mw0113-9mw0321-and-9mw0311-in-russia-and-eurasian-economic-union-countries/ 2022-12-21T01:12:13+00:00 https://medicaex.com/prnewswire/mentice-ab-publ-receives-an-order-of-11-million-usd-for-simulation-solutions-from-beijing-huanya-zhitong-on-behalf-of-the-chinese-medical-education-association/ 2022-12-21T00:12:12+00:00 https://medicaex.com/prnewswire/digital-mental-health-company-thoughtfull-partners-with-fwd-to-provide-science-backed-and-technology-enabled-mental-health-solutions-for-customers-in-hong-kong-and-thailand/ 2022-12-20T22:12:16+00:00 https://medicaex.com/prnewswire/carcell-welcomes-prof-harvey-lodish-as-chair-of-its-scientific-advisory-board/ 2022-12-20T22:12:12+00:00 https://medicaex.com/prnewswire/emeterm-enters-walmart-and-best-buy-with-new-technology/ 2022-12-20T16:12:17+00:00 https://medicaex.com/prnewswire/lunit-ai-can-help-tuberculosis-screening-in-prisons-as-published-in-the-lancet-regional-health-americas/ 2022-12-20T14:12:18+00:00 https://medicaex.com/prnewswire/cgtn-the-chinese-are-sharing-their-covid-experiences-as-policy-optimized/ 2022-12-20T14:12:10+00:00 https://medicaex.com/prnewswire/the-top-8-best-places-to-work-in-philippines-for-2022-revealed/ 2022-12-20T12:12:06+00:00 https://medicaex.com/prnewswire/epidemic-modified-approach-ensures-maximum-benefit/ 2022-12-20T11:12:11+00:00 https://medicaex.com/prnewswire/korea-ginseng-corp-enhances-its-reputation-as-a-leading-herbal-dietary-brand-by-revealing-a-new-set-of-stocking-stuffers/ 2022-12-20T08:12:11+00:00 https://medicaex.com/prnewswire/cgtn-infrastructure-vaccines-and-space-china-arab-sci-tech-cooperation/ 2022-12-20T03:12:08+00:00 https://medicaex.com/prnewswire/actinogen-announces-first-patient-treated-in-depression-and-cognitive-impairment-phase-2-clinical-trial/ 2022-12-19T15:14:04+00:00 https://medicaex.com/prnewswire/clinical-trial-approval-for-the-companys-novel-adjuvanted-recombinant-shingles-vaccine-rec610-in-the-philippines/ 2022-12-19T15:13:52+00:00 https://medicaex.com/prnewswire/shen-peng-awarded-charitable-entrepreneur-of-for-good-awards-2022/ 2022-12-19T15:13:45+00:00 https://medicaex.com/prnewswire/carsgen-presents-data-from-china-pivotal-phase-ii-trial-of-bcma-car-t-zevor-cel-ct053-at-2022-ash-annual-meeting/ 2022-12-19T13:12:19+00:00 https://medicaex.com/prnewswire/live-from-ash-2022-ascentage-pharma-presents-latest-data-of-apg-2575-including-encouraging-results-of-the-combination-with-btki-in-patients-with-r-r-cll-sll/ 2022-12-19T13:12:18+00:00 https://medicaex.com/prnewswire/swiss-reju-wins-prestigious-cosmopolitan-best-of-the-best-beauty-award-taking-innovative-slimming-and-body-contouring-to-the-next-level/ 2022-12-19T13:12:15+00:00 https://medicaex.com/prnewswire/versius-adopted-for-gynaecological-and-urogynaecological-procedures-at-frances-perry-house/ 2022-12-19T13:12:15+00:00 https://medicaex.com/prnewswire/seekin-receives-ce-ivd-mark-approval-for-seekincure-cancer-recurrence-monitoring-kit/ 2022-12-19T13:12:13+00:00 https://medicaex.com/prnewswire/tg-immunopharma-tgi-announces-fda-clearance-of-ind-application-for-tgi-2-a-novel-anti-pvrig-therapeutic-antibody/ 2022-12-19T13:12:11+00:00 https://medicaex.com/prnewswire/prenetics-acquires-act-genomics-creating-a-leader-in-comprehensive-cancer-genetics-and-precision-oncology/ 2022-12-19T13:12:11+00:00 https://medicaex.com/prnewswire/frost-sullivan-recognizes-vitalconnect-with-the-2022-new-product-innovation-award-for-its-leading-edge-wearable-patient-monitoring-device/ 2022-12-19T12:12:16+00:00 https://medicaex.com/prnewswire/pharmabcine-announces-collaboration-agreement-with-msd-to-evaluate-anti-vista-antibody-pmc-309-in-combination-with-keytruda-pembrolizumab/ 2022-12-19T11:12:18+00:00 https://medicaex.com/prnewswire/ascletis-announces-notice-of-issuance-of-the-u-s-patent-for-oral-viral-polymerase-inhibitor-asc10-and-its-derivatives/ 2022-12-19T11:12:11+00:00 https://medicaex.com/prnewswire/novavax-announces-pricing-of-65-million-public-offering-of-common-stock/ 2022-12-19T10:12:12+00:00 https://medicaex.com/prnewswire/smartfuture-launches-first-responder-platform/ 2022-12-19T09:12:12+00:00 https://medicaex.com/prnewswire/smartcardia-earns-frost-sullivans-2022-global-new-product-innovation-award-in-the-cardiac-monitoring-wearables-industry/ 2022-12-19T08:12:20+00:00 https://medicaex.com/prnewswire/novavax-announces-pricing-of-150-million-offering-of-convertible-senior-notes/ 2022-12-19T08:12:16+00:00 https://medicaex.com/prnewswire/ncds-in-focus-act-now-summit-organized-by-viatris/ 2022-12-19T02:12:16+00:00 https://medicaex.com/prnewswire/wuxi-biologics-shanghai-co-ltd-removed-from-the-u-s-commerce-departments-unverified-list/ 2022-12-19T01:12:16+00:00 https://medicaex.com/prnewswire/education-cannot-wait-receives-mother-teresa-memorial-award-for-social-justice-2022/ 2022-12-18T15:12:11+00:00 https://medicaex.com/prnewswire/asierisbladder-cancer-diagnostic-drug-hexvix-completed-dosing-of-first-patient-in-real-world-clinical-study/ 2022-12-16T08:12:24+00:00 https://medicaex.com/prnewswire/asieris-enrolled-first-patient-for-its-phase-ii-clinical-study-of-oral-apl-1202-in-combination-with-tislelizumab-a-pd-1-inhibitor-as-neoadjuvant-therapy-for-muscle-invasive-bladder-cancer/ 2022-12-16T08:12:24+00:00 https://medicaex.com/prnewswire/sonarmed-airway-monitoring-system-applauded-by-frost-sullivan-for-providing-real-time-visualization-for-accurate-troubleshooting-with-its-endotracheal-tube-airway-monitor/ 2022-12-16T08:12:22+00:00 https://medicaex.com/prnewswire/harrison-ai-named-on-the-2022-cb-insights-digital-health-150-list/ 2022-12-16T08:12:22+00:00 https://medicaex.com/prnewswire/bsr-korea-introduces-wizbiosolutions-inc-as-2022-global-procurement-marketer/ 2022-12-16T08:12:22+00:00 https://medicaex.com/prnewswire/china-pharma-holdings-inc-announced-that-several-products-are-included-in-the-catalogue-of-medicines-for-people-infected-with-covid-19/ 2022-12-16T08:12:18+00:00 https://medicaex.com/prnewswire/biorchestra-receives-citation-from-the-korean-minister-of-trade-industry-and-energy/ 2022-12-16T08:12:18+00:00 https://medicaex.com/prnewswire/duality-announced-the-appointment-of-dr-pasi-a-janne-as-member-of-sab/ 2022-12-16T07:12:16+00:00 https://medicaex.com/prnewswire/nevisense-for-skin-barrier-evaluation-included-in-large-australian-birth-cohort-study/ 2022-12-16T07:12:16+00:00 https://medicaex.com/prnewswire/smartfuture-launches-sdk-to-enable-plug-and-play-remote-patient-monitoring-in-existing-healthcare-payer-and-provider-applications/ 2022-12-16T03:12:21+00:00 https://medicaex.com/prnewswire/infermedica-celebrates-record-year-accelerating-momentum-into-2023/ 2022-12-16T03:12:17+00:00 https://medicaex.com/prnewswire/hitgen-announces-research-agreement-with-nitrase-therapeutics-focused-on-dna-encoded-library-based-drug-discovery/ 2022-12-16T01:12:23+00:00 https://medicaex.com/prnewswire/gracell-biotechnologies-presents-clinical-data-for-fastcar-t-gc012f-for-high-risk-newly-diagnosed-multiple-myeloma-demonstrating-100-overall-response-rate/ 2022-12-16T00:12:33+00:00 https://medicaex.com/prnewswire/immorna-receives-ind-clearance-to-conduct-a-phase-1-2-study-of-jcxh-221-a-broadly-protective-mrna-based-covid-19-vaccine/ 2022-12-16T00:12:27+00:00 https://medicaex.com/prnewswire/pharming-announces-positive-interim-analysis-data-from-open-label-extension-study-of-leniolisib-in-presentation-at-the-64th-american-society-of-hematology-ash-annual-meeting-and-exposition/ 2022-12-16T00:12:26+00:00 https://medicaex.com/prnewswire/veeva-pulse-shows-digitally-enabled-field-teams-are-using-hcp-time-more-effectively-in-asia-pacific/ 2022-12-15T18:12:30+00:00 https://medicaex.com/prnewswire/xingimaging-and-mitro-biotech-co-ltd-to-deliver-full-service-cro-operations-to-china/ 2022-12-15T17:12:20+00:00 https://medicaex.com/prnewswire/china-recalibrates-its-covid-19-response-strategy/ 2022-12-15T17:12:17+00:00 https://medicaex.com/prnewswire/siemens-earns-the-frost-sullivan-2022-company-of-the-year-award-for-its-pioneering-approach-in-the-data-center-industry/ 2022-12-15T14:12:16+00:00 https://medicaex.com/prnewswire/newtowns-apple-to-highly-saturated-global-molecular-market-tiangen-tguide-s16-automated-nucleic-acid-extractor-showcased-at-cell-bio-2022/ 2022-12-15T13:12:24+00:00 https://medicaex.com/prnewswire/innovent-and-lg-chem-announce-strategic-collaboration-for-tigulixostat-a-novel-non-purine-xanthine-oxidase-inhibitor-for-the-treatment-of-gout-disease/ 2022-12-15T13:12:19+00:00 https://medicaex.com/prnewswire/everest-medicines-announces-new-mrna-rabies-vaccine-program-and-achievement-of-preclinical-proof-of-concept-milestone/ 2022-12-15T07:12:39+00:00 https://medicaex.com/prnewswire/ind-application-of-biosyngens-cell-therapy-brg01-for-nasopharyngeal-cancer-approved-by-china-nmpa/ 2022-12-15T06:12:17+00:00 https://medicaex.com/prnewswire/sirnaomics-announces-positive-interim-data-from-phase-iib-clinical-trial-of-stp705-in-adults-with-cutaneous-squamous-cell-carcinoma-in-situ/ 2022-12-15T06:12:17+00:00 https://medicaex.com/prnewswire/program-cd47-provided-the-cmc-service-by-genscript-probio-to-innobationbio-will-further-be-advanced-by-the-joint-venture-between-liminatus-pharma-llc-and-iris-acquisition-corp/ 2022-12-15T06:12:14+00:00 https://medicaex.com/prnewswire/revir-therapeutics-to-present-at-rna-targeted-drug-discovery-summit/ 2022-12-15T04:12:26+00:00 https://medicaex.com/prnewswire/see-mode-technologies-receives-health-canada-approval-for-ai-software-that-automatically-analyses-and-reports-breast-thyroid-ultrasound-scans/ 2022-12-15T04:12:21+00:00 https://medicaex.com/prnewswire/circulating-tumor-cell-detection-by-menarini-groups-cellsearch-system-leading-to-genomic-profiling-of-myeloma-cells-shows-potential-for-non-invasive-management-of-multiple-myeloma-patients-at/ 2022-12-15T04:12:19+00:00 https://medicaex.com/prnewswire/hovione-and-gea-announce-a-strategic-collaboration-to-advance-continuous-tableting/ 2022-12-15T04:12:19+00:00 https://medicaex.com/prnewswire/alternative-bio-launches-with-usd-15m-series-seed-financing-led-by-eight-roads-ventures-with-f-prime-capital-and-sequoia-china-seed-fund/ 2022-12-15T01:12:18+00:00 https://medicaex.com/prnewswire/comirnaty-bivalent-vaccine-arrives-in-hong-kong-sar-and-macau-sar-and-will-soon-be-available-to-the-local-residents/ 2022-12-15T01:12:15+00:00 https://medicaex.com/prnewswire/superior-results-of-the-comparative-study-of-the-companys-recombinant-two-component-covid-19-vaccine-recov-as-compared-to-international-mainstream-mrna-vaccine/ 2022-12-15T00:12:17+00:00 https://medicaex.com/prnewswire/sirnaomics-executive-director-dr-xiaochang-dai-to-deliver-keynote-speech-at-biohk2022/ 2022-12-15T00:12:17+00:00 https://medicaex.com/prnewswire/sirnaomics-executive-director-dr-xiaochang-dai-to-deliver-keynote-speech-at-biohk2022-2/ 2022-12-14T21:12:21+00:00 https://medicaex.com/prnewswire/australian-scientists-honoured-with-the-grand-hamdan-award/ 2022-12-14T21:12:17+00:00 https://medicaex.com/prnewswire/introducing-kapsul-atlas-protective-athletic-gear/ 2022-12-14T17:12:13+00:00 https://medicaex.com/prnewswire/createrna-announces-positive-top-line-results-from-phase-1-clinical-trials-of-qr052107b-tablet-in-healthy-volunteers/ 2022-12-14T13:12:28+00:00 https://medicaex.com/prnewswire/corvia-medical-announces-randomization-of-first-patient-in-the-responder-hf-confirmatory-trial/ 2022-12-14T13:12:25+00:00 https://medicaex.com/prnewswire/verisim-life-earns-frost-sullivan-competitive-strategy-leadership-award-for-best-practices-in-ai-enabled-preclinical-development-industry/ 2022-12-14T13:12:21+00:00 https://medicaex.com/prnewswire/histosonics-announces-100-million-in-financings-and-new-appointment-to-its-board-of-directors/ 2022-12-14T13:12:21+00:00 https://medicaex.com/prnewswire/biosion-announces-research-collaboration-with-immunogen-to-create-novel-antibody-drug-conjugates/ 2022-12-14T13:12:21+00:00 https://medicaex.com/prnewswire/bpk9-international-hospital-achieves-gha-accreditation-for-medical-travel-services/ 2022-12-14T12:12:18+00:00 https://medicaex.com/prnewswire/remegens-rc118-for-injection-targeting-claudin-18-2-in-patients-with-gastric-and-pancreatic-cancers-granted-two-orphan-drug-designations-by-u-s-fda/ 2022-12-14T11:12:20+00:00 https://medicaex.com/prnewswire/another-very-successful-year-for-the-zeiss-group/ 2022-12-14T10:12:14+00:00 https://medicaex.com/prnewswire/luye-pharma-and-dch-auriga-establish-an-exclusive-distribution-partnership-and-jointly-launch-the-we-care-about-mental-health-initiative/ 2022-12-14T07:12:31+00:00 https://medicaex.com/prnewswire/youth-at-risk-of-being-left-behind-in-asia-pacific-tuberculosis-response-regional-forum-spotlights/ 2022-12-14T04:12:19+00:00 https://medicaex.com/prnewswire/apr-applied-pharma-research-a-subsidiary-of-relief-therapeutics-is-a-finalist-in-the-2022-rare-disease-international-film-festival/ 2022-12-14T04:12:15+00:00 https://medicaex.com/prnewswire/sk-biopharmaceuticals-unveils-vision-for-digital-healthcare/ 2022-12-14T03:12:11+00:00 https://medicaex.com/prnewswire/csl-announces-next-ceo-managing-director/ 2022-12-13T17:12:17+00:00 https://medicaex.com/prnewswire/treadwell-therapeutics-announces-a-presentation-at-the-2022-ash-annual-meeting-featuring-a-clinical-trial-update-on-cfi-400945-an-oral-plk4-inhibitor/ 2022-12-13T15:12:19+00:00 https://medicaex.com/prnewswire/patients-and-doctors-agree-on-treatment-goals-only-half-the-time-according-to-jnccn-study-on-people-with-neuroendocrine-tumors/ 2022-12-13T14:12:20+00:00 https://medicaex.com/prnewswire/meditech-awarded-2022-north-america-enabling-technology-leadership-award-by-frost-sullivan/ 2022-12-13T14:12:15+00:00 https://medicaex.com/prnewswire/biovaxys-sarbecovirus-vaccine-interim-data-excellent-emerging-safety-tolerability-profile-with-bvx-1021/ 2022-12-13T04:12:13+00:00 https://medicaex.com/prnewswire/wuxi-vaccines-establishes-new-vaccines-cdmo-facility-in-china/ 2022-12-13T03:12:13+00:00 https://medicaex.com/prnewswire/bsr-korea-introduces-healcerion-co-ltd-as-2022-global-procurement-marketer/ 2022-12-12T23:12:21+00:00 https://medicaex.com/prnewswire/alphamab-oncology-presented-clinical-data-of-kn026-combined-with-docetaxel-in-first-line-treatment-of-her2-positive-recurrent-metastatic-breast-cancer-at-sabcs-2022/ 2022-12-12T23:12:16+00:00 https://medicaex.com/prnewswire/alphamab-oncology-presented-clinical-data-of-kn026-combined-with-docetaxel-as-neoadjuvant-treatment-for-her2-positive-early-or-locally-advanced-breast-cancer-at-sabcs-2022/ 2022-12-12T22:12:19+00:00 https://medicaex.com/prnewswire/ascletis-announces-positive-phase-i-clinical-results-of-oral-rdrp-inhibitor-asc10-for-covid-19/ 2022-12-12T16:12:20+00:00 https://medicaex.com/prnewswire/jitc-publication-of-akesos-ligufalimabcd47-monoclonal-antibody-mechanism-shows-promising-antitumor-efficacy-and-favorable-safety-profile/ 2022-12-12T15:12:21+00:00 https://medicaex.com/prnewswire/bsr-korea-introduces-core-value-as-2022-global-procurement-marketer/ 2022-12-12T14:12:26+00:00 https://medicaex.com/prnewswire/suvoda-launches-ecoa-specific-language-and-design-toolkit-as-solution-moves-to-second-phase-of-early-adopter-program/ 2022-12-12T13:12:28+00:00 https://medicaex.com/prnewswire/new-international-consensus-on-cgm-clinical-trial-metrics-aims-to-spur-diabetes-treatment-advances/ 2022-12-12T13:12:28+00:00 https://medicaex.com/prnewswire/turn-biotechnologies-changes-paradigm-in-skin-rejuvenation/ 2022-12-12T13:12:28+00:00 https://medicaex.com/prnewswire/alphamab-oncology-presented-final-analysis-of-kn046-combined-with-nab-paclitaxel-in-the-treatment-of-mtnbc-at-sabcs-2022/ 2022-12-12T13:12:19+00:00 https://medicaex.com/prnewswire/innovent-presents-phase-1b-clinical-data-of-ibi188-anti-cd47-monoclonal-antibody-at-the-2022-american-society-of-hematology-annual-meeting/ 2022-12-12T13:12:19+00:00 https://medicaex.com/prnewswire/jw-therapeutics-presents-latest-clinical-data-on-carteyva-in-follicular-lymphoma-and-mantle-cell-lymphoma-at-the-64th-ash-annual-meeting/ 2022-12-12T11:12:17+00:00 https://medicaex.com/prnewswire/goodwin-biotechnology-inc-is-now-gbi-as-part-of-their-rebranding-initiative-on-their-30-year-anniversary/ 2022-12-12T09:12:17+00:00 https://medicaex.com/prnewswire/the-1st-boao-international-conference-on-real-world-studies-of-medical-products-held-in-hainan/ 2022-12-12T07:12:17+00:00 https://medicaex.com/prnewswire/china-further-optimizes-covid-19-response-with-new-measures/ 2022-12-12T04:12:15+00:00 https://medicaex.com/prnewswire/innovent-presents-phase-ib-clinical-data-of-ibi939-anti-tigit-monoclonal-antibody-in-previously-untreated-pd-l1-selected-nsclc-at-the-2022-european-society-for-medical-oncology-immuno-oncology-congr/ 2022-12-12T02:12:17+00:00 https://medicaex.com/prnewswire/innovent-presents-phase-ib-clinical-data-update-of-ibi110-anti-lag-3-monoclonal-antibody-at-the-2022-european-society-for-medical-oncology-immuno-oncology-congress/ 2022-12-12T02:12:17+00:00 https://medicaex.com/prnewswire/sk-biopharmaceuticals-partner-angelini-pharma-launches-cenobamate-in-france/ 2022-12-12T02:12:17+00:00 https://medicaex.com/prnewswire/daewoong-pharmaceutical-announces-success-in-developing-a-new-antidiabetic-medication-and-its-aims-to-enter-the-market-in-over-50-countries-by-2030/ 2022-12-10T23:12:25+00:00 https://medicaex.com/prnewswire/liscures-phase-2-drug-candidate-granted-orphan-drug-designation-odd-from-us-fda/ 2022-12-10T23:12:17+00:00 https://medicaex.com/prnewswire/trialwire-awarded-by-frost-sullivan-for-innovative-clinical-trial-patient-recruitment-technology-platform/ 2022-12-09T20:12:17+00:00 https://medicaex.com/prnewswire/asia-embraces-the-dawn/ 2022-12-09T17:12:17+00:00 https://medicaex.com/prnewswire/treadwell-therapeutics-announces-a-presentation-at-the-2022-sabcs-annual-meeting-featuring-a-clinical-trial-update-on-cfi-402257-a-best-in-class-ttk-inhibitor/ 2022-12-09T15:12:21+00:00 https://medicaex.com/prnewswire/pharmabcine-to-participate-in-the-41th-annual-j-p-morgan-healthcare-conference-and-biotech-showcase-2023-during-jpm-week/ 2022-12-09T11:12:22+00:00 https://medicaex.com/prnewswire/neeuro-and-institute-of-mental-health-launch-home-based-attention-training-programme/ 2022-12-09T10:12:30+00:00 https://medicaex.com/prnewswire/cgtn-what-has-china-done-in-its-nearly-3-years-of-covid-19-fight/ 2022-12-09T09:12:16+00:00 https://medicaex.com/prnewswire/a-successful-conclusion-of-camtech-summit-powered-by-prudential-cambodia-2022/ 2022-12-09T08:12:14+00:00 https://medicaex.com/prnewswire/shenzhen-holds-2022-global-investment-promotion-conference-to-build-a-magnet-for-international-investors/ 2022-12-09T04:12:13+00:00 https://medicaex.com/prnewswire/antengene-appoints-amily-zhang-as-its-chief-medical-officer/ 2022-12-09T00:12:22+00:00 https://medicaex.com/prnewswire/sk-biopharmaceuticals-wins-export-award-for-cenobamate/ 2022-12-08T15:12:33+00:00 https://medicaex.com/prnewswire/pharming-announces-publication-of-data-from-phase-3-study-of-leniolisib-in-patients-with-apds-in-ashs-blood/ 2022-12-08T15:12:23+00:00 https://medicaex.com/prnewswire/apollo-proton-cancer-centre-successfully-performs-asias-1st-brain-bypass-surgery-on-twin-children-with-moya-moya-disease/ 2022-12-08T14:12:21+00:00 https://medicaex.com/prnewswire/pgtg-successfully-develops-sgf-bone-derived-factor-to-restore-the-skeletal-system/ 2022-12-08T14:12:21+00:00 https://medicaex.com/prnewswire/waterdrop-ceo-peng-shen-elected-as-vice-chairman-of-alumni-association-of-zhejiang-university-the-hong-kong-polytechnic-university-joint-center/ 2022-12-08T14:12:16+00:00 https://medicaex.com/prnewswire/cabio-showcases-the-latest-research-results-and-innovative-solutions-at-food-ingredients-europe-2022/ 2022-12-08T14:12:16+00:00 https://medicaex.com/prnewswire/medical-metaverse-company-apoqlar-receives-fda-510k-clearance-for-its-mixed-reality-surgical-planning-platform-vsi-holomedicine/ 2022-12-08T13:12:28+00:00 https://medicaex.com/prnewswire/novavax-phase-3-covid-19-omicron-trial-supports-the-continued-and-future-use-of-novavax-prototype-vaccine-as-a-booster/ 2022-12-08T12:12:21+00:00 https://medicaex.com/prnewswire/traditional-chinese-medicine-lianhua-qingwen-attracted-eyes-in-the-annual-national-conference-of-pharmaceutical-society-of-nigeria/ 2022-12-08T12:12:21+00:00 https://medicaex.com/prnewswire/japanese-healthcare-startup-ubie-inc-closes-extended-series-c-round-at-45-million-establishes-subsidiary-in-ny/ 2022-12-08T09:12:36+00:00 https://medicaex.com/prnewswire/parnell-pharmaceuticals-holdings-ltd-announces-commencement-of-rights-offering/ 2022-12-08T00:12:18+00:00 https://medicaex.com/prnewswire/program-cd47-provided-the-cmc-service-by-genscript-probio-to-innobationbio-will-further-be-advanced-by-the-joint-venture-between-liminatus-pharma-llc-and-iris-acquisition-corp-2/ 2022-12-07T22:12:23+00:00 https://medicaex.com/prnewswire/ktg-makes-donations-to-support-communities-affected-by-west-java-earthquake/ 2022-12-07T16:12:28+00:00 https://medicaex.com/prnewswire/healthcare-summit-convened-to-address-maternal-fetal-outcomes-in-sub-saharan-africa/ 2022-12-07T16:12:22+00:00 https://medicaex.com/prnewswire/lost-childhood-a-tight-knit-network-to-combat-abuse-and-distress/ 2022-12-07T14:12:18+00:00